Psilocybin treatment in people with anorexia nervosa showed feasibility, acceptable safety, and possible symptom relief in an early clinical study

Psilocybin treatment for anorexia nervosa showed early signs of feasibility, acceptable safety, and possible symptom improvement in a small clinical study discussed by Scientific American. People with anorexia received psilocybin in a controlled therapeutic setting, with researchers watching for changes in eating-disorder symptoms, mood, and psychological flexibility. Anorexia remains difficult to treat and carries one of the highest mortality rates among psychiatric disorders, which makes new treatment approaches especially important. Psilocybin may help by disrupting rigid thought patterns, reducing entrenched self-perception, and creating a window for therapeutic change rather than acting as a standalone cure. Early-stage findings remain preliminary because the study was small and not designed to prove efficacy on its own. Larger controlled trials are needed to test whether benefits hold up, which patients respond best, and how psychedelic therapy could fit into broader eating-disorder care.